Views & Analysis Rebooting the healthcare system post-COVID-19 Janssen’s Iris Zemzoum looks at seven ways the healthcare and pharma sectors need to change in the wake of COVID-19.
Views & Analysis Janssen: ‘Open dialogue’ needed with HTAs to improve access The world of life sciences is changing rapidly, and the traditional ways of assessing drugs may no longer be fit for purpose.
News J&J brings forward start of COVID-19 vaccine trial to next m... Johnson & Johnson has announced it has brought forward the start of its COVID-19 vaccine by around two months to mid-July.
Views & Analysis Deep Dive: Market Access - Breaking Barriers In this issue of Deep Dive we look at the changing landscape for pharma market access and start to assess the impact of the COVID-19 pandemic.
Views & Analysis Janssen’s Gaëtan Leblay on leading during the COVID-19 crisi... COVID-19 is putting unimaginable pressure on healthcare systems and the companies looking for solutions to end the pandemic.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
